Why the study?
Does the AGT M235T polymorphism increase the risk of preeclampsia?
Does the AGT M235T polymorphism increase the risk of preeclampsia?
The TT genotype of the AGT M235T polymorphism is associated with an increased risk of preeclampsia, particularly in Caucasians and multigravida.
Should not yet alter preeclampsia management; leaves open whether AGT M235T informs targeted prevention in validated cohorts.
OBJECTIVE: Preeclampsia a hypertensive disorder of pregnancy that mainly manifests as high blood pressure and proteinuria. Angiotensinogen (AGT) plays important roles in the regulation of blood pressure. The purpose of this study was to investigate the relationship between AGT M235T polymorphism and risk of preeclampsia using a meta-analysis. METHODS: In this meta-analysis, 22 studies were selected by searching PubMed, EMBASE, ISI and CNKI databases up to October 2011. Crude odds ratios with corresponding 95% confidence intervals were used to evaluate the association between the AGT M235T polymorphism and risk of preeclampsia. Subgroup analyses were conducted by ethnicity and parity. RESULTS: The TT genotype of the AGT M235T polymorphism was associated with elevated risk of preeclampsia in the overall analysis. In subgroup analysis according to ethnicity, increased risks were also found in Caucasians. After stratification based on parity, the excess risk was found in multigravida. CONCLUSIONS: These results showed that the TT genotype may play critical roles in the development of preeclampsia.
No takes yet. Share an insight, caveat, or question.
Ni et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: